The fate of chymopapain injected for therapy of intervertebral disc disease.
D000510:Alpha-Globulins / Q000494:pharmacology; D000818:Animals; D000941:Antigens; D001798:Blood Proteins / Q000494:pharmacology; D003545:Cysteine / Q000494:pharmacology; D004285:Dogs; D004492:Edetic Acid / Q000494:pharmacology; D010450:Endopeptidases / Q000008:administration & dosage / Q000097:blood / Q000378:metabolism / Q000627:therapeutic use* / Q000652:urine; D000882:Haplorhini; D006801:Humans; D007267:Injections; D007275:Injections, Intravenous; D007403:Intervertebral Disc; D007405:Intervertebral Disc Displacement / Q000188:drug therapy*; D008259:Macroglobulins / Q000494:pharmacology; D051379:Mice; D010206:Papain; D010446:Peptide Fragments / Q000032:analysis; D011480:Protease Inhibitors; D011817:Rabbits / Q000276:immunology; D011863:Radioimmunoassay; D051381:Rats; D013045:Species Specificity
D000510:Alpha-Globulins; D000941:Antigens; D001798:Blood Proteins; D008259:Macroglobulins; D010446:Peptide Fragments; D011480:Protease Inhibitors; D004492:Edetic Acid; D010450:Endopeptidases; D010206:Papain; D003545:Cysteine